How steroid hormones act on the endothelium-insights by atomic force microscopy

Pflugers Archiv European Journal of Physiology

Volumn 456, Issue 1, 2008, Pages 51-60

  Hillebrand, Uta ^a   Hausberg, Martin ^a   Lang, Detlef ^a   Stock, Christian ^b   Riethmüller, Christoph ^b   Callies, Chiara ^b   Büssemaker, Eckhart ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; Atomic force microscopy; Endothelium; Glucocorticoids; Imaging; Nitric oxide; Sex hormones

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; CARIPORIDE; DEXAMETHASONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN RECEPTOR ANTAGONIST; ESTRADIOL; GLUCOCORTICOID; PREDNISOLONE; PROGESTERONE; SEX HORMONE; SPIRONOLACTONE; STEROID HORMONE; TESTOSTERONE;

ATOMIC FORCE MICROSCOPY; CELL FUNCTION; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CELL VOLUME; ELASTICITY; ENDOTHELIUM; ENDOTHELIUM CELL; HORMONE ACTION; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RIGIDITY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL SHAPE; ELASTICITY; ENDOTHELIUM, VASCULAR; GONADAL STEROID HORMONES; HUMANS; MICROSCOPY, ATOMIC FORCE; NITRIC OXIDE;

EID: 43149083072     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0411-3     Document Type: Review

References (67)

1. Abiose AK, Mansoor GA, Barry M, Soucier R, Nair CK, Hager D (2004) Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. Am J Cardiol 93:1564-1566
2. Anantharam A, Tian Y, Palmer LG (2006) Open probability of the epithelial sodium channel is regulated by intracellular sodium. J Physiol 574:333-347
3. Binnig G, Quate CF, Gerber C (1986) Atomic force microscope. Phys Rev Lett 56:930-934
4. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME (1997) Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 10:1326-1334
5. Bouzin C, Brouet A, De Vriese J, Dewever J, Feron O (2007) Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J Immunol 178:1505-1511
6. Brandes RP (2007) Avoiding vicious circles: mineralocorticoid receptor antagonism prevents vascular oxidative stress early after myocardial infarction. Hypertension 50:842-843
7. Brotman DJ, Girod JP, Garcia MJ, Patel JV, Gupta M, Posch A, Saunders S, Lip GY, Worley S, Reddy S (2005) Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 90:3202-3208
8. Brown NJ (2005) Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 14:235-241
9. Chen W, Lee JY, Hsieh WC (2002) Effects of dexamethasone and sex hormones on cytokine-induced cellular adhesion molecule expression in human endothelial cells. Eur J Dermatol 12:445-448
10. Collins P, Shay J, Jiang C, Moss J (1994) Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90:1964-1968
11. David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Reboucas NA, Tostes RC (2001) Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 38:692-696
12. Davies PF, Zilberberg J, Helmke BP (2003) Spatial microstimuli in endothelial mechanosignaling. Circ Res 92:359-370
13. Funder JW (2005) The nongenomic actions of aldosterone. Endocr Rev 26:313-321
14. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M (2001) Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 280:1300-1306
15. Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Gonzalez-Gay MA (2006) Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. J Rheumatol 33:74-78
16. Gorelik J, Zhang Y, Sanchez D, Shevchuk A, Frolenkov G, Lab M, Klenerman D, Edwards C, Korchev Y (2005) Aldosterone acts via an ATP autocrine/paracrine system: the Edelman ATP hypothesis revisited. Proc Natl Acad Sci USA 102:15000-15005
17. Hillebrand U, Hausberg M, Stock C, Shahin V, Nikova D, Riethmuller C, Kliche K, Ludwig T, Schillers H, Schneider SW, Oberleithner H (2006) 17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange. Cardiovasc Res 69:916-924
18. Hillebrand U, Schillers H, Riethmuller C, Stock C, Wilhelmi M, Oberleithner H, Hausberg M (2007) Dose-dependent endothelial cell growth and stiffening by aldosterone: endothelial protection by eplerenone. J Hypertens 25:639-647
19. Huang A, Sun D, Koller A, Kaley G (1997) Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Physiol 272:H1804-H1809
20. Hutcheson IR, Griffith TM (1996) Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release. Br J Pharmacol 118:720-726
21. Ibegbuna V, Nicolaides AN, Sowade O, Leon M, Geroulakos G (1997) Venous elasticity after treatment with Daflon 500 mg. Angiology 48:45-49
22. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T (2003) Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87
23. Ji JY, Jing H, Diamond SL (2003) Shear stress causes nuclear localization of endothelial glucocorticoid receptor and expression from the GRE promoter. Circ Res 92:279-285
24. Kanashiro CA, Khalil RA (2001) Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol Cell Physiol 280:C34-C45
25. Khalil RA (2005) Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46:249-254
26. Kidoaki S, Matsuda T (2007) Shape-engineered vascular endothelial cells: nitric oxide production, cell elasticity, and actin cytoskeletal features. J Biomed Mater Res A 81:728-735
27. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M (2002) Increased carotid wall elastic modulus and fibronectin in aldosterone-salt- treated rats: effects of eplerenone. Circulation 106:2848-2853
28. Ladage D, Brixius K, Hoyer H, Steingen C, Wesseling A, Malan D, Bloch W, Schwinger RH (2006) Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol 33:720-724
29. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 13:189-197
30. Mayranpaa MI, Resendiz JC, Heikkila HM, Lindstedt KA, Kovanen PT (2007) Improved identification of endothelial erosion by simultaneous detection of endothelial cells (CD31/CD34) and platelets (CD42b). Endothelium 14:81-87
31. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M (2006) Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 48:165-171
32. Oberleithner H (2005) Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 67:1680-1682
33. Oberleithner H (2007) Is the vascular endothelium under the control of aldosterone? Facts and hypothesis. Pflugers Arch 454:187-193
34. Oberleithner H, Giebisch G, Geibel J (1993) Imaging the lamellipodium of migrating epithelial cells in vivo by atomic force microscopy. Pflugers Arch 425:506-510
35. Oberleithner H, Ludwig T, Riethmuller C, Hillebrand U, Albermann L, Schafer C, Shahin V, Schillers H (2004) Human endothelium: target for aldosterone. Hypertension 43:952-956
36. Oberleithner H, Riethmuller C, Ludwig T, Hausberg M, Schillers H (2006) Aldosterone remodels human endothelium. Acta Physiol (Oxf) 187:305-312
37. Oberleithner H, Riethmuller C, Ludwig T, Shahin V, Stock C, Schwab A, Hausberg M, Kusche K, Schillers H (2006) Differential action of steroid hormones on human endothelium. J Cell Sci 119:1926-1932
38. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M (2007) Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 104:16281-16286
39. Oberleithner H, Schillers H, Wilhelmi M, Butzke D, Danker T (2000) Nuclear pores collapse in response to CO2 imaged with atomic force microscopy. Pflugers Arch 439:251-255
40. Oberleithner H, Weigt M, Westphale HJ, Wang W (1987) Aldosterone activates Na+/H+ exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc Natl Acad Sci USA 84:1464-1468
41. Orshal JM, Khalil RA (2004) Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286:R233-R249
42. Peng X, Haldar S, Deshpande S, Irani K, Kass DA (2003) Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41:378-381
43. Pesen D, Hoh JH (2005) Micromechanical architecture of the endothelial cell cortex. Biophys J 88:670-679
44. Pesen D, Hoh JH (2005) Modes of remodeling in the cortical cytoskeleton of vascular endothelial cells. FEBS Lett 579:473-476
45. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL (2003) Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42:49-55
46. Quaschning T, Ruschitzka F, Shaw S, Luscher TF (2001) Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension 37:801-805
47. Riethmuller C, Jungmann P, Wegener J, Oberleithner H (2006) Bradykinin shifts endothelial fluid passage from para- to transcellular routes. Pflugers Arch 453:157-165
48. Safar ME, Lacolley P (2007) Disturbance of macro- and microcirculation: relations with pulse pressure and cardiac organ damage. Am J Physiol Heart Circ Physiol 293:H1-H7
49. Schneider SW, Larmer J, Henderson RM, Oberleithner H (1998) Molecular weights of individual proteins correlate with molecular volumes measured by atomic force microscopy. Pflugers Arch 435:362-367
50. Schneider SW, Matzke R, Radmacher M, Oberleithner H (2004) Shape and volume of living aldosterone-sensitive cells imaged with the atomic force microscope. Methods Mol Biol 242:255-279
51. Schneider SW, Yano Y, Sumpio BE, Jena BP, Geibel JP, Gekle M, Oberleithner H (1997) Rapid aldosterone-induced cell volume increase of endothelial cells measured by the atomic force microscope. Cell Biol Int 21:759-768
52. Schnittler HJ, Schneider SW, Raifer H, Luo F, Dieterich P, Just I, Aktories K (2001) Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflugers Arch 442:675-687
53. Shahin V (2006) Route of glucocorticoid-induced macromolecules across the nuclear envelope as viewed by atomic force microscopy. Pflugers Arch 453:1-9
54. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR (2004) Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69:537-542
55. Simoncini T, Mannella P, Fornari L, Caruso A, Willis MY, Garibaldi S, Baldacci C, Genazzani AR (2004) Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145:5745-5756
56. Struthers AD, MacDonald TM (2004) Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 61:663-670
57. Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN (2002) Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 106:2967-2972
58. Thompson LP, Weiner CP (1997) Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619. Circulation 95:709-714
59. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Forstermann U (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96:13357-13362
60. Wang Q, Chiang ET, Lim M, Lai J, Rogers R, Janmey PA, Shepro D, Doerschuk CM (2001) Changes in the biomechanical properties of neutrophils and endothelial cells during adhesion. Blood 97:660-668
61. Wang Q, Pfeiffer GR, Stevens T, Doerschuk CM (2002) Lung microvascular and arterial endothelial cells differ in their responses to intercellular adhesion molecule-1 ligation. Am J Respir Crit Care Med 166:872-877
62. Wellman GC, Bonev AD, Nelson MT, Brayden JE (1996) Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. Circ Res 79:1024-1030
63. Wong S, Brennan FE, Young MJ, Fuller PJ, Cole TJ (2007) A direct effect of aldosterone on endothelin-1 gene expression in vivo. Endocrinology 148:1511-1517
64. Wu L, Xiao B, Jia X, Zhang Y, Lu S, Chen J, Long M (2007) Impact of carrier stiffness and microtopology on two-dimensional kinetics of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) interactions. J Biol Chem 282:9846-9854
65. Wu Y, Zhou Z, Meyerhoff ME (2007) In vitro platelet adhesion on polymeric surfaces with varying fluxes of continuous nitric oxide release. J Biomed Mater Res A 81:956-963
66. Wynne FL, Khalil RA (2003) Testosterone and coronary vascular tone: implications in coronary artery disease. J Endocrinol Invest 26:181-186
67. Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2:1-12